Tesamorelin
Synthetic analog of growth-hormone-releasing factor.
Editorial review: August 13, 2026Evidence snapshot
An FDA-approved product is indicated to reduce excess abdominal fat in certain adults with HIV and lipodystrophy; approval does not extend to general weight loss or unapproved copies.
Reported experiences
Abdominal fat, body composition
Reported topics are not established benefits.Risks and unknowns
Glucose effects, swelling, joint discomfort, injection reactions, contraindications
Context matters. Approval of one medicine, formulation, or use does not establish approval of products sold online or other uses. This page is educational and does not provide dosing or treatment advice.
Member discussion
Compare experiences with care.
Before posting: Describe firsthand observations and uncertainty. Do not prescribe, arrange transactions, or post private health information.
Join the discussion
Verified members can contribute to compound conversations.
No approved member reports yet. Thoughtful first contributions are welcome.